Article may be outdated

This article is 8 days old. Some details may have changed since publication.

Science Daily·3 min read·medium

Common osteoporosis drugs linked to 24% lower dementia risk in major study

Common osteoporosis drugs linked to 24% lower dementia risk in major study
✦AI Summary

Researchers at the University of Hong Kong found that nitrogen-containing bisphosphonates, commonly used to treat osteoporosis, are linked to a 24% lower risk of dementia. The study suggests these existing medications could be repurposed to help prevent or delay Alzheimer's and other cognitive decline.

Why it matters

Repurposing affordable, existing drugs could provide a scalable solution to the growing global dementia crisis, which is projected to affect 139 million people by 2050.

✦Dive DeeperCreate a free account to unlock

A common class of drugs used to treat osteoporosis may have an unexpected benefit: lowering the risk of Alzheimer's disease and other forms of dementia. In a study involving more than 120,000 older adults, researchers at the University of Hong Kong (HKUMed) found that patients taking certain medications to strengthen their bones were significantly less likely to develop dementia.

The medications, known as nitrogen-containing bisphosphonates (NBPs), are widely prescribed to prevent bone loss and fractures. The findings suggest that these established treatments could potentially serve a second purpose by helping protect the aging brain. The research, conducted by scientists in the Department of Pharmacology and Pharmacy at HKUMed's LKS Faculty of Medicine, was published in Alzheimer's & Dementia .

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
sciencehealth
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in